hikma pharmaceuticals plc annual report 2013 how we perFormed in 2013 a very SucceSSful year hikma delivered excellent revenue and earnings growth 2013 highlights 2013 200813 2013 1 revenue revenue cagr adjusted operating margin $1,365m 19% 30.3% 2013 2013 2013 products marketed operating cash Flow employees 710 $337m 7,067 2013 REVENUE BY SEGMENT % 2013 REVENUE BY REGION % 1.
Europe 3 20% 7% and the rest of the world 2 2 1 Before the amortisation of intangible assets excluding software and exceptional items 04 strategic report 2013 highlights ADJUSTED OPERATING PROFIT 1 REVENUE $ MILLION $ MILLION 23% 113% 13 13 1,365 413 12 12 1,109 194 PROFIT ATTRIBUTABLE TO 2 EBITDA $ MILLION SHAREHOLDERS $ MILLION 89% 112% 13 13 427 212 12 12 226 100 3 DIVIDEND PER SHARE CENTS BASIC EARNINGS PER SHARE CENTS 25% 111% 13 13 20.0 107.6 12 12 16.0 51.1 1 Before the amortisation of intangible assets excluding software and exceptional items 2 earnings before interest, tax, depreciation and amortisation.
eBitda is stated before impairment charges for intangible and fixed assets 3 in addition, the Board has recommended a special full year dividend of 7.0 cents per share in2013 to reflect the exceptional performance of the group in 2013 05
